Parenteral Drugs (India) Limited Statistics
Parenteral Drugs (India) Limited (PDPL) Stock Statistics & Valuation Metrics
Total Valuation
Parenteral Drugs (India) Limited has a market cap or net worth of $101.08M. The enterprise value is $1173.07T.
- Market Cap
- $101.08M
- Enterprise Value
- $1173.07T
Share Statistics
Parenteral Drugs (India) Limited has 29,816,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 29,816,300
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Parenteral Drugs (India) Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is <0.01%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- -0.16
- Return on Invested Capital (ROIC)
- <0.01%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 93.47K
- Profits Per Employee
- -840.06K
- Employee Count
- 909
- Asset Turnover
- 0.02
- Inventory Turnover
- 5.32
Valuation Ratios
The current PE Ratio of Parenteral Drugs (India) Limited is -0.11. Parenteral Drugs (India) Limited’s PEG ratio is -0.00.
- PE Ratio
- -0.11
- PS Ratio
- 1.19
- PB Ratio
- -0.01
- Price to FCF
- -20.94
- Price to Operating Cash Flow
- -17.91
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Parenteral Drugs (India) Limited had revenue of 84.96M and earned -763.62M in profits. Earnings per share was -25.61.
- Revenue
- 84.96M
- Gross Profit
- 30.31M
- Operating Income
- -117.56K
- Pretax Income
- -1.09M
- Net Income
- -763.62M
- EBITDA
- 372.69M
- Earnings Per Share (EPS)
- -25.61
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- -0.16
Dividends & Yields
Parenteral Drugs (India) Limited pays an annual dividend of $1.13, resulting in a dividend yield of ―
- Dividend Per Share
- $1.13
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4.78%
- Earnings Yield
- -883.10%
Important Dates
Parenteral Drugs (India) Limited upcoming earnings date is ―, Before Open (Confirmed).
- Last Earnings Date
- ―
- Next Earnings Date
- ―
- Ex-Dividend Date
- Sep 13, 2010
Financial Position
Parenteral Drugs (India) Limited as a current ratio of 0.06, with Debt / Equity ratio of -13.01%
- Current Ratio
- 0.06
- Quick Ratio
- 0.06
- Debt to Market Cap
- 9.99
- Net Debt to EBITDA
- 2.88
- Interest Coverage Ratio
- -0.00
Taxes
In the past 12 months, Parenteral Drugs (India) Limited has paid -327.64K in taxes.
- Income Tax
- -327.64K
- Effective Tax Rate
- 0.30
Enterprise Valuation
Parenteral Drugs (India) Limited EV to EBITDA ratio is 3.15, with an EV/FCF ratio of -243.02.
- EV to Sales
- 13.81
- EV to EBITDA
- 3.15
- EV to Free Cash Flow
- -243.02
- EV to Operating Cash Flow
- -243.02
Balance Sheet
Parenteral Drugs (India) Limited has $1,000.00 in cash and marketable securities with $1.07B in debt, giving a net cash position of -$1.07B billion.
- Cash & Marketable Securities
- $1,000.00
- Total Debt
- $1.07B
- Net Cash
- -$1.07B
- Net Cash Per Share
- -$35.95
- Tangible Book Value Per Share
- -$276.33
Margins
Gross margin is 35.67%, with operating margin of -0.14%, and net profit margin of -898.77%.
- Gross Margin
- 35.67%
- Operating Margin
- -0.14%
- Pretax Margin
- -1.28%
- Net Profit Margin
- -898.77%
- EBITDA Margin
- 438.65%
- EBIT Margin
- -33.89%

